Professor Aylward is a Member of the Innovation Centre within SAHMRI Heart Health and leading the development of Education Programmes. Professor Aylward is Professor of Medicine at Flinders University and the Director of Strategic Relationships within the Southern Adelaide Local Health Network.
Professor Aylward is a Cardiologist with a long involvement over two decades in Clinical Trials and has been a National Co-ordinator, Member of a number of International Steering & Executive Committees in Cardiology particularly in areas of Acute Coronary Syndromes, Lipid Management, Atrial Fibrillation and Heart Failure.
Professor Aylward was Co-chair and author of the initial Australian Guidelines for the Management of Acute Coronary Syndromes 2006 and was a Member of the 2017 Acute Coronary Syndrome Guidelines Writing Committee of the National Heart Foundation and Cardiac Society of Australia & New Zealand.
Stephen Nicholls commenced as the Director of Monash Heart and Professor of Cardiology at Monash University in late 2018. He is a Principal Research Fellow of the National Health and Medical Research Council of Australia. He completed his medical training in Adelaide, cardiology training in Newcastle and his PhD at the Heart Research Institute, focusing on the anti-inflammatory properties of high-density lipoproteins. After a postdoctoral fellowship in plaque imaging, he was appointed to faculty at the Cleveland Clinic, where he served as the Medical Director of the Atherosclerosis Imaging Core Laboratory and Cardiovascular Director of the Cleveland Clinic Coordinating Center for Clinical Research. He returned to Australia in 2012 to take up the role of Deputy Director and Heart Health Theme Leader at the South Australian Health and Medical Research Institute (SAHMRI). He has published more than 600 original manuscripts, conference proceedings and book chapters, including in the New England Journal of Medicine, Lancet, Journal of the American Medical Association and Nature Medicine. He is a Past President of the Australian Atherosclerosis Society and Treasurer of the Cardiac Society of Australia and New Zealand. He is an inaugural Fellow of the Australian Academy of Health and Medical Sciences. His major research interests include studying the impact of metabolic factors influencing heart disease, development of novel plaque imaging modalities in clinical practice and performing large scale clinical trials of novel cardioprotective therapies.
Julie is a Director for Evidence to Practice and is responsible for oversight of all operational activities. She works closely with clients to ensure that each meeting meets their expectations. Additionally, Julie has more than two decades of experience working in the Clinical Research sphere and her primary role is to attract and manage new Clinical Trial and commercial opportunities for the Victorian Heart Institute at Monash University and to establish new relationships with potential trial partners. She is well connected internationally to many of the major pharmaceutical and academic research partners. Julie has extensive leadership and business training and holds an MBA.
Georgia manages all of the logistics for Evidence to Practice within Australia and internationally. Georgia has worked in the cardiovascular clinical trial space within the Heart Health Theme and Clinical Research at SAHMRI over the past five years. More recently, Georgia manages the education and training portfolio at the Victorian Heart Institute, Monash University. She is also completing her Masters in Psychology.